Abstract
Epidemiological studies have long indicated a possible role for dietary flavonoids, notably flavones and flavonols, in the prevention of a range of degenerative diseases, e.g., cancer, diabetes, cardiovascular diseases, and neurological disorders like Parkinson’s and Alzheimer’s disease. The flavonoids are a large and variable group of compounds, comprising thousands of different structures. The bulk of the dietary flavonoids occur as glycosides.
The effect of flavonoid aglycones and their corresponding glycosides on cell metabolism and etiology of degenerative diseases has been a topic of interest for a number of decades. In contrast, the role of the metabolic products of dietary flavonoid that reach all parts of the human body through systemic circulation, has received much less attention.
Studies on animal and human metabolism have shown that the amount of flavone and flavonol glycosides which is absorbed intact is negligible; the bulk is absorbed only after deglycosylation. Thus, dietary glycosides are not likely to play a direct role in chemoprevention. However, the sugar groups on glycosides can greatly affect the bioavailability of flavones and flavonols. Flavonoids linked with indigestible sugars are not absorbed in the small intestine but are transported through the digestive tract to be degraded by gut bacteria in the large intestine.
The compounds that directly play a role in the prevention of degenerative diseases are most likely not dietary flavones themselves but rather their metabolites and conjugation products.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alfa HH, Arroo RRJ (2019) Over 3 decades of research on dietary flavonoid antioxidants and cancer prevention: what have we achieved? Phytochem Rev 18:989–1004. https://doi.org/10.1007/s11101-019-09632-0
Ames BN (1983) Dietary carcinogens and Anticarcinogens – oxygen radicals and degenerative diseases. Science 221:1256–1263. https://doi.org/10.1126/science.6351251
Amoedo ND, Obre E, Rossignol R (2017) Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy. Biochim Biophys Acta 1858:674–685. https://doi.org/10.1016/j.bbabio.2017.02.005
Aragonès G, Danesi F, Del Rio D, Menac P (2017) The importance of studying cell metabolism when testing the bioactivity of phenolic compounds. Trends Food Sci Technol 69(Part B): 230–242. https://doi.org/10.1016/j.tifs.2017.02.001
Arts IC, Sesink AL, Faassen-Peters M, Hollman PC (2004) The type of sugar moiety is a major determinant of the small intestinal uptake and subsequent biliary excretion of dietary quercetin glycosides. Br J Nutr 91(6):841–847. https://doi.org/10.1079/BJN20041123
Barron D, Di Pietro A, Dumontet C, McIntosh DB (2002) Isoprenoid flavonoids are new leads in the modulation of chemoresistance. Phytochem Rev 1:325–332. https://doi.org/10.1023/A:1026099520073
Boumendjel A, Di Pietro A, Dumontet C, Barron D (2002) Recent advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrug resistance. Med Res Rev 22(5):512–529. https://doi.org/10.1002/med.10015
Boumendjel A, Macalou S, Valdameri G, Pozza A, Gauthier C, Arnaud O, Nicolle E, Magnard S, Falson P, Terreux R, Carrupt PA, Payen L, Di Pietro A (2011) Targeting the multidrug ABCG2 transporter with flavonoidic inhibitors: in vitro optimization and in vivo validation. Curr Med Chem 18(22): 3387–3401. https://doi.org/10.2174/092986711796504736
Boyd MR, Paull KD (1995) Some practical considerations and applications of the national cancer institute in vitro anticancer drug discovery screen. Drug Dev Res 34:91–109. https://doi.org/10.1002/ddr.430340203
Braune A, Blaut M (2016) Bacterial species involved in the conversion of dietary flavonoids in the human gut. Gut Microbes 7(3):216–234. https://doi.org/10.1080/19490976.2016.1158395
Brune A, Schink B (1992) Phloroglucinol pathway in the strictly anaerobic Pelobacter acidigallici: fermentation of trihydroxybenzenes to acetate via triacetic acid. Arch. Microbiol 157:417–424. https://doi.org/10.1007/BF00249098
Cermak R, Landgraf S, Wolffram S (2003) The bioavailability of quercetin in pigs depends on the glycoside moiety and on dietary factors. J Nutr 133(2802):2807. https://doi.org/10.1093/jn/133.9.2802
Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A (1998) Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid-binding sites on mouse P-glycoprotein. Proc Natl Acad Sci U S A 95(17):9831–9836. https://doi.org/10.1073/pnas.95.17.9831
Coussens NP, Braisted JC, Peryea T, Sittampalam GS, Simeonov A, Hall MD (2017) Small-molecule screens: a gateway to cancer therapeutic agents with case studies of food and drug administration–approved drugs. Pharmacol Rev 69:479–496. https://doi.org/10.1124/pr.117.013755
Day AJ, Mellon F, Barron D, Sarrazin G, Morgan MRA, Williamson G (2001) Human metabolism of dietary flavonoids: identification of plasma metabolites of quercetin. Free Radic Res 35:941–952. https://doi.org/10.1080/10715760100301441
Day AJ, Gee JM, DuPont MS, Johnson IT, Williamson G (2003) Absorption of quercetin-3-glucoside and quercetin-4′-glucoside in the rat small intestine: the role of lactase phlorizin hydrolase and the sodium-dependent glucose transporter. Biochem Pharmacol 65(7):1199–1206. https://doi.org/10.1016/s0006-2952(03)00039-x
Del Bo C, Bernardi C, Marino M, Porrini M, Tucci M, Guglielmetti S, Cherubini A, Carrieri B, Kirkup B, Kroon P, Zamora-Ros R, Hidalgo Liberona N, Andres-Lacueva C, Riso P (2019) Systematic review on polyphenol intake and health outcomes: is there sufficient evidence to define a health-promoting polyphenol-rich dietary pattern? Nutrients 11(6):Art. No 1355. https://doi.org/10.3390/nu11061355
DeVita VT Jr, Chu E (2008) A history of Cancer chemotherapy. Cancer Res 68(21):8643–8653. https://doi.org/10.1158/0008-5472.CAN-07-6611
Dixon RA, Pasinetti GM (2010) Flavonoids and Isoflavonoids: from plant biology to agriculture and neuroscience. Plant Physiol 154:453–457. https://doi.org/10.1104/pp.110.161430
EFSA (2010) Scientific opinion on the substantiation of health claims related to various food(s)/food constituent(s) and protection of cells from premature aging, antioxidant activity, antioxidant content and antioxidant properties, and protection of DNA, proteins and lipids from oxidative damage pursuant to article 13(1) of regulation (EC) No 1924/2006. EFSA J 8(2): 1489–1552. https://doi.org/10.2903/j.efsa.2010.1489
European Parliament, Council of the European Union (2004) Directive 2004/24/EC of the European Parliament and of the council of 31 march 2004, amending, as regards traditional herbal medicinal products, directive 2001/83/EC on the community code relating to medicinal products for human use. Off J Eur Union L136:85–90
Fang Y, Cao W, Liang F, Xia M, Pan S, Xu X (2019) Structure affinity relationship and docking studies of flavonoids as substrates of multidrug-resistant associated protein 2 (MRP2) in MDCK/MRP2 cells. Food Chem 291:101–109. https://doi.org/10.1016/j.foodchem.2019.03.111
FDA (2017) Classification of products as drugs and devices and additional product classification issues. Guidance Document, U.S. Department of Health and Human Services, Food and Drug Administration, Office of Combination Products
Goveia J, Pircher A, Conradi L, Kalucka J, Lagani V, Dewerchin M, Eelen G, DeBerardinis RJ, Wilson ID, Carmeliet P (2016) Meta-analysis of clinical metabolic profiling studies in cancer: challenges and opportunities. EMBO Mol Med 8:1134–1142. https://doi.org/10.15252/emmm.201606798
Grosso G, Micek A, Godos J, Pajak A, Sciacca S, Galvano F, Giovannucci EL (2017) Dietary flavonoid and Lignan intake and mortality in prospective cohort studies: systematic review and dose-response meta-analysis. Am J Epidemiol 185(12):1304–1316. https://doi.org/10.1093/aje/kww207
Guo Y, Bruno RS (2015) Endogenous and exogenous mediators of quercetin bioavailability. J Nutr Biochem 26(3):201–210. https://doi.org/10.1016/j.jnutbio.2014.10.008
Hanske L, Engst W, Loh G, Sczesny S, Blaut M, Braune A (2013) Contribution of gut bacteria to the metabolism of cyanidin 3-glucoside in human microbiota-associated rats. Br J Nutr 109:1433–1441. https://doi.org/10.1017/S0007114512003376
Harborne JB, Williams CA (1995) Anthocyanins and other flavonoids. Nat Prod Rep 12:639–657
Harborne JB, Williams CA (1998) Anthocyanins and other flavonoids. Nat Prod Rep 15:631–651
Harborne JB, Williams CA (2001) Anthocyanins and other flavonoids. Nat Prod Rep 18:310–333
Hostetler GL, Ralston RA, Schwartz SJ (2017) Flavones: food sources, bioavailability, metabolism, and bioactivity. Adv Nutr 8(3):423–435. https://doi.org/10.3945/an.116.012948
Hou DX, Kumamoto T (2010) Flavonoids as protein kinase inhibitors for cancer chemoprevention: direct binding and molecular modelling. Antioxid Redox Signal 13(5):691–719. https://doi.org/10.1089/ars.2009.2816
Imran M, Rauf A, Shah ZA, Saeed F, Imran A, Arshad MU, Ahmad B, Bawazeer S, Atif M, Peters DG, Mubarak MS (2018) Chemo-preventive and therapeutic effect of the dietary flavonoid kaempferol: a comprehensive review. Phytother Res 33(2):263–275. https://doi.org/10.1002/ptr.6227
Isgut M, Rao M, Yang C, Subrahmanyam V, Rida PCG, Aneja R (2017) Application of combination high-throughput phenotypic screening and target identification methods for the discovery of natural product-based combination drugs. Med Res Rev 38(2):504–524. https://doi.org/10.1002/med.21444
Jay M, Viricel MR, Gonnet JF (2006) C-Glycosylflavonoids. In: Andersen ØM, Markham KR (eds) Flavonoids: chemistry, biochemistry and applications. CRC Press, Boca Raton, pp 857–915
Jin H, Leng Q, Li C (2012) Dietary flavonoid for preventing colorectal neoplasms. Cochrane Database Syst Rev 2012(8):Art. No.: CD009350. https://doi.org/10.1002/14651858.CD009350.pub2
Johnson JL, Rupasinghe SG, Stefani F, Schuler MA, Mejia EG (2011) Citrus flavonoids luteolin, apigenin, and quercetin inhibit glycogen synthase kinase-3β enzymatic activity by lowering the interaction energy within the binding cavity. J Med Food 14:325–333. https://doi.org/10.1089/jmf.2010.0310
Khan F, Niaz K, Maqbool F, Hassan FI, Abdollahi M, Nagulapalli Venkata KC, Nabavi SM, Bishayee A (2016) Molecular targets underlying the anticancer effects of quercetin: an update. Nutrients 8:Art No 529. https://doi.org/10.3390/nu8090529
Kobori M, Takahashi Y, Sakurai M, Akimoto Y, Tsushida T, Oike H, Ippoushi K (2016) Quercetin suppresses immune cell accumulation and improves mitochondrial gene expression in adipose tissue of diet-induced obese mice. Mol Nutr Food Res 60(2):300–312. https://doi.org/10.1002/mnfr.201500595. Epub 2015 Nov 24
Kure A, Nakagawa K, Kondo M, Kato S, Kimura F, Watanabe A, Shoji N, Hatanaka S, Tsushida T, Miyazawa T (2016) Metabolic fate of luteolin in rats: its relationship to anti-inflammatory effect. J Agric Food Chem 64:4246–4254. https://doi.org/10.1021/acs.jafc.6b00964
Li Y, Fang H, Xu W (2007) Recent advance in the research of flavonoids as anticancer agents. Mini Rev Med Chem 7(7):663–678. https://doi.org/10.2174/138955707781024463
Luo Z, Morgan MRA, Day AJ (2015) Transport of trans-tiliroside (kaempferol-3-β-D-(6″-p-coumaroyl)-glucopyranoside) and related flavonoids across Caco-2 cells, as a model of absorption and metabolism in the small intestine. Xenobiotica 45(8):722–730. https://doi.org/10.3109/00498254.2015.1007492
Manthey JA, Guthrie N (2002) Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J Agric Food Chem 50(21):5837–5843. https://doi.org/10.1021/jf020121d
Menezes JCJMDS, Orlikova B, Morceau F, Diederich M (2016) Natural and synthetic flavonoids: structure-activity relationship and chemotherapeutic potential for the treatment of leukemia. Crit Rev Food Sci Nutr 56 Suppl 1:S4–S28. https://doi.org/10.1080/10408398.2015.1074532
Moffat JG, Rudolph J, Bailey D (2014) Phenotypic screening in cancer drug discovery – past, present and future. Nat Rev Drug Discov 13:588–602. https://doi.org/10.1038/nrd4366
Mohos V, Pánovics A, Fliszár-Nyúl E, Schilli G, Hetényi C, Mladěnka P, Needs PW, Kroon PA, Pethő G, Poór M (2019) Inhibitory effects of quercetin and its human and microbial metabolites on xanthine oxidase enzyme. Int J Mol Sci 20(11):Article Nr E2681. https://doi.org/10.3390/ijms20112681
Needs PW, Kroon PA (2006) Convenient syntheses of metabolically important quercetin glucuronides and sulfates. Tetrahedron 62(29):6862–6868. https://doi.org/10.1016/j.tet.2006.04.102
Odontuya G, Hoult JRS, Houghton PJ (2005) Structure-activity relationship for antiinflammatory effect of luteolin and its derived glycosides. Phytother. Res 19(9):782–786. https://doi.org/10.1002/ptr.1723
O’Leary KA, Day AJ, Needs PW, Mellon FA, O’Brien NM, Williamson G (2003) Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: the role of human β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochem Pharmacol 65:479–491. https://doi.org/10.1016/s0006-2952(02)01510-1
Pannala AS, Chan ST, O’Brien JP, Rice-Evans AC (2001) Flavonoid B-ring chemistry and antioxidant activity: fast reaction kinetics. Biochem Biophys Res Commun 282:1161–1168. https://doi.org/10.1006/bbrc.2001.4705
Pimpão RC, Ventura MR, Ferreira RB, Williamson G, Santos CN (2015) Phenolic sulfates as new and highly abundant metabolites in human plasma after ingestion of a mixed berry fruit purée. Br J Nutr 113(3):454–463. https://doi.org/10.1017/S0007114514003511
Plochmann K, Korte G, Koutsilieri E, Richling E, Riederer P, Rethwilm A, Schreier P, Scheller C (2007) Structure-activity relationships of flavonoid-induced cytotoxicity on human leukemia cells. Arch Biochem Biophys 460(1):1–9. https://doi.org/10.1016/j.abb.2007.02.003
Potì F, Santi D, Spaggiari G, Zimetti F, Zanotti I (2019) Polyphenol health effects on cardiovascular and neurodegenerative disorders: a review and meta-analysis. Int J Mol Sci 20(2):Art. Nr. 351. https://doi.org/10.3390/ijms20020351
Ried K, Fakler P, Stocks NP (2017) Effect of cocoa on blood pressure. Cochrane Database of Syst Rev 2017(4):Art. No.: CD008893. https://doi.org/10.1002/14651858.CD008893.pub3
Rodríguez-García C, Sánchez-Quesada C, Gaforio JJ (2019) Dietary flavonoids as cancer chemopreventive agents: an updated review of human studies. Antioxidants 8(5):Art. Nr. 137. https://doi.org/10.3390/antiox8050137
Saito K, Yonekura-Sakakibara K, Nakabayashi R, Higashi Y, Yamazaki M, Tohge T, Fernie AR (2013) The flavonoid biosynthetic pathway in Arabidopsis: structural and genetic diversity. Plant Physiol Biochem 72:21–34. https://doi.org/10.1016/j.plaphy.2013.02.001
Sankaranarayanan R, Valiveti CK, Kumar DR, Van Slambrouck S, Kesharwani SS, Seefeldt T, Scaria J, Tummala H, Bhat GJ (2019) The flavonoid metabolite 2,4,6-Trihydroxybenzoic acid is a CDK inhibitor and an anti-proliferative agent: a potential role in Cancer prevention. Cancers 11(3):Art Nr E427. https://doi.org/10.3390/cancers11030427
Schoefer L, Mohan R, Schwiertz A, Braune A, Blaut M (2003) Anaerobic degradation of flavonoids by Clostridium orbiscindens. Appl Environ Microbiol 69(10):5849–5954. https://doi.org/10.1128/aem.69.10.5849-5854.2003
Scotti L, Mendonca FJB, Moreira DRM, da Silva MS, Pitta IR, Scotti MT (2012) SAR, QSAR and docking of anticancer flavonoids and variants: a review. Curr Top Med Chem 12(24):2785–2809. https://doi.org/10.2174/1568026611212240007
Sen P, Orešič M (2019) Metabolic modeling of human gut microbiota on a genome scale: an overview. Metabolites 9(2):Art Nr. 22. https://doi.org/10.3390/metabo9020022
Singh AN, Baruah MM, Sharma N (2017) Structure based docking studies towards exploring potential antiandrogen activity of selected phytochemicals against prostate cancer. Sci Rep 7:Art. Nr 1955. https://doi.org/10.1038/s41598-017-02023-51
Smeriglio A, Barreca D, Bellocco E, Trombetta D (2016) Chemistry, pharmacology and health benefits of anthocyanins. Phytother Res 30(8):1265–1286. https://doi.org/10.1002/ptr.5642
Spencer JPE, Abd El Mohsen MM, Rice-Evans C (2004) Cellular uptake and metabolism of flavonoids and their metabolites: implications for their bioactivity. Arch Biochem Biophys 423:148–161. https://doi.org/10.1016/j.abb.2003.11.010
Suen J, Thomas J, Kranz A, Vun S, Miller M (2016) Effect of flavonoids on oxidative stress and inflammation in adults at risk of cardiovascular disease: a systematic review. Healthcare 4(3):Art. No.: E69. https://doi.org/10.3390/healthcare4030069
Swinney DC, Anthony J (2011) How were new medicines discovered? Nat Rev Drug Discov 10:507–510. https://doi.org/10.1038/nrd3480
Takasawa R, Takahashi S, Saeki K, Sunaga S, Yoshimori A, Tanuma S (2008) Structure-activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects. Bioorg Med Chem 6(7):3969–3975. https://doi.org/10.1016/j.bmc.2008.01.031
Tang Z, Li M, Zhang X, Hou W (2016) Dietary flavonoid intake and the risk of stroke: a dose-response meta-analysis of prospective cohort studies. BMJ Open 2016(6):e008680. https://doi.org/10.1136/bmjopen-2015-008680
Veitch NG, Grayer RJ (2007) Flavonoids and their glycosides, including anthocyanins. Nat Prod Rep 25:555–611. https://doi.org/10.1039/b718040n
Veitch NG, Grayer RJ (2011) Flavonoids and their glycosides, including anthocyanins. Nat Prod Rep 28:1626–1695. https://doi.org/10.1039/c1np00044f
Walle T (2007) Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Semin. Cancer Biol 17(5):354–362. https://doi.org/10.1016/j.semcancer.2007.05.002
Walgren RA, Karnaky KJ Jr, Lindenmayer GE, Walle T (2000) Efflux of dietary flavonoid quercetin 4′-beta-glucoside across human intestinal Caco-2 cell monolayers by apical multidrug resistance-associated protein-2. J Pharmacol Exp Ther 294(3):830–836
Wang L, Chen Q, Zhu L, Li Q, Zeng X, Lu L, Hu M, Wang X, Liu Z (2017) Metabolic disposition of luteolin is mediated by the interplay of UDP-glucuronosyl transferases and catechol-O-methyltransferases in rats. Drug Metab Dispos 45:306–315. https://doi.org/10.1124/dmd.116.073619
Wermuth CG, Ganellin CR, Lindberg P, Mitscher LA (1998) Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998). Pure Appl Chem 70(5):1129–1143. https://doi.org/10.1351/pac199870051129
Williams CA, Grayer RJ (2004) Anthocyanins and other flavonoids. Nat Prod Rep 21:539–573. https://doi.org/10.1039/b311404j
Williamson G, Kay CD, Crozier A (2018) The bioavailability, transport, and bioactivity of dietary flavonoids: a review from a historical perspective. Comprehensive Reviews in Food Science and Food Safety 17(5):1054–1112. https://doi.org/10.1111/1541-4337.12351
Wolffram S, Blöck M, Ader P (2002) Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine. J Nutr 132(4): 630–635. https://doi.org/10.1093/jn/132.4.630
Wu Q, Needs PW, Lu Y, Kroon PA, Ren D, Yang X (2018a) Different antitumor effects of quercetin, quercetin-3′-sulfate and quercetin-3-glucuronide in human breast cancer MCF-7 cells. Food Funct 9(3):1736–1746. https://doi.org/10.1039/c7fo01964e
Wu Q, Kroon PA, Shao H, Needs PW, Yang X (2018b) Differential effects of quercetin and two of its derivatives, isorhamnetin and isorhamnetin-3-glucuronide, in inhibiting the proliferation of human breast-cancer MCF-7 cells. J Agric Food Chem 66(27):7181–7189. https://doi.org/10.1021/acs.jafc.8b02420
Xiao J (2017) Dietary flavonoid aglycones and their glycosides: which show better biological significance? Crit Rev Food Sci Nutr 57(9):1874–1905. https://doi.org/10.1080/10408398.2015.1032400
Xiao J, Capanoglu E, Jassbi AR, Miron A (2016) Advance on the flavonoid C-glycosides and health benefits. Crit Rev Food Sci Nutr 56(Suppl 1):S29–S45. https://doi.org/10.1080/10408398.2015.1067595
Zhang H, Tsao R (2016) Dietary polyphenols, oxidative stress and antioxidant and anti-inflammatory effects. Curr Opin Food Sci 8:33–42. https://doi.org/10.1016/j.cofs.2016.02.002
Zhang Y, Tie X, Bao B, Wu X, Zhang Y (2007) Metabolism of flavone C-glucosides and p-coumaric acid from antioxidant of bamboo leaves (AOB) in rats. Br J Nutr 97(3):484–494. https://doi.org/10.1017/S0007114507336830
Zhang J, Yang PL, Gray NS (2009) Targeting cancer with small molecule kinase inhibitors. Nat Rev Cancer 9:28–39. https://doi.org/10.1038/nrc2559
Zhang Q, Raheem KS, Botting NP, Slawin AMZ, Kay CD, O’Hagan D (2012) Flavonoid metabolism: the synthesis of phenolic glucuronides and sulfates as candidate metabolites for bioactivity studies of dietary flavonoids. Tetrahedron 68(22):4194–4201. https://doi.org/10.1016/j.tet.2012.03.100
Zhao LL, Yuan XY, Wang JB, Feng YF, Ji F, Li ZY, Bian JL (2019) A review on flavones targeting serine/threonine protein kinases for potential anticancer drugs. Bioorg Med Chem 27(5): 677–685. https://doi.org/10.1016/j.bmc.2019.01.027
Zheng W, Thorne N, McKew JC (2013) Phenotypic screens as a renewed approach for drug discovery. Drug Discov Today 18(21–22):1067–1073. https://doi.org/10.1016/j.drudis.2013.07.001
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this entry
Cite this entry
Arroo, R.R.J., Wang, M.F., Bhambra, A.S. (2020). Chemopreventive Potential of Flavones, Flavonols, and their Glycosides. In: Xiao, J., Sarker, S., Asakawa, Y. (eds) Handbook of Dietary Phytochemicals. Springer, Singapore. https://doi.org/10.1007/978-981-13-1745-3_5-1
Download citation
DOI: https://doi.org/10.1007/978-981-13-1745-3_5-1
Received:
Accepted:
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1745-3
Online ISBN: 978-981-13-1745-3
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences